Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000252851 | SCV000313387 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Center for Pediatric Genomic Medicine, |
RCV000514465 | SCV000610059 | likely benign | not provided | 2017-08-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000514465 | SCV001827960 | likely benign | not provided | 2021-10-06 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002278200 | SCV002566317 | likely benign | Ehlers-Danlos syndrome | 2020-12-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002379081 | SCV002670951 | benign | Cardiovascular phenotype | 2019-07-05 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002494756 | SCV002800236 | benign | Ehlers-Danlos syndrome due to tenascin-X deficiency; Vesicoureteral reflux 8 | 2021-07-07 | criteria provided, single submitter | clinical testing |